Top Markets
Coin of the day
Eagle Pharmaceuticals, Inc. Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.

EGRX
Classifica tra le azioni #33346
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on... Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company’s product portfolio offers RYANODEX for malignant hyperthermia; and BELRAPZO and BENDEKA for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma. It also produces PEMFEXY, a ready-to-dilute liquid form of pemetrexed injection, indicated in combination with cisplatin for the initial treatment of patients with malignant pleural mesothelioma and non-small cell lung cancer; BARHEMSYS, a selective dopamine-2 (D2) and dopamine-3 (D3) receptor antagonist indicated in adults for prevention of postoperative nausea and vomiting (PONV); BYFAVO, a benzodiazepine indicated for the induction and maintenance of procedural sedation in adults. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an anti-toxin agent in Phase 2 development for the treatment of severe pneumonia in combination with traditional antibacterial drugs; ENA-001 developed by Enalare, an agnostic respiratory stimulant for respiratory depression; EA-114, novel and proprietary formulation of fulvestrant developed for hormone-receptor-positive (HR+) metastatic breast cancer. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat cancer. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Prezzo delle azioni
$0.595
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$7.83M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-81.41%
Paese
US
Scambia Eagle Pharmaceuticals, Inc. (EGRX)

Categoria

Storico del prezzo dell'azione per Eagle Pharmaceuticals, Inc. (EGRX)
Prezzo di chiusura più alto: $0.27 il 2026-08-01

Prezzo di chiusura più basso: $12.89 il 2014-02-01
Storico del prezzo dell'azione di Eagle Pharmaceuticals, Inc. dal 2014 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 96.79%
2025 -29.61%
2024 -87.52%
2023 -82.65%
2022 -38.74%
2021 7.84%
2020 -20.71%
2019 39.37%
2018 -25.22%
2017 -26.15%
2016 -16.70%
2015 591.76%
2014 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$161.26 22.94%
DE
$35.97 20.03%
JP
$222.59 36.04%
CH
$20.77 10.96%
IN